We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Under the three-year award, FluGen will conduct two challenge-studies with RedeeFlu. In these studies, half of the participants will be vaccinated and half will receive a placebo but all will subsequently be infected with an influenza virus.